Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8969867 | Vaccine | 2005 | 5 Pages |
Abstract
The phosphate content of commercial ovalbumin was increased from 1.8 to 3.2Â mol PO4/mol ovalbumin by conjugation of phosphoserine and reduced to 1.2 or 0.14Â mol PO4/mol ovalbumin by treatment with potato acid phosphatase. The four ovalbumin samples were completely adsorbed by aluminum hydroxide adjuvant due to electrostatic attraction of the negatively charged ovalbumin and the positively charged aluminum hydroxide adjuvant as well as by ligand exchange of phosphate groups with surface hydroxyl groups. Elution from aluminum hydroxide adjuvant upon exposure to interstitial fluid was inversely related to the degree of phosphorylation of the ovalbumin. The ovalbumin sample containing 3.2Â mol PO4/mol ovalbumin did not elute while the ovalbumin sample containing 0.14Â mol PO4/mol ovalbumin eluted completely from aluminum hydroxide adjuvant during exposure to interstitial fluid for 30Â min. Adsorption of the four ovalbumin samples by aluminum phosphate adjuvant was directly related to the degree of phosphorylation of ovalbumin. Adsorption was due to ligand exchange as an electrostatic repulsive force operated between the negatively charged ovalbumin samples and the negatively charged aluminum phosphate adjuvant. The potential for ligand exchange decreased as the phosphorylation of ovalbumin decreased. Elution upon exposure to interstitial fluid was inversely related to the degree of phosphorylation and was more extensive than observed for aluminum hydroxide adjuvant. Adsorption of ovalbumin by aluminum-containing adjuvants and elution upon exposure to interstitial fluid can be controlled by the degree of phosphorylation of both ovalbumin and the aluminum-containing adjuvant.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Garry L. Morefield, Dongping Jiang, Ilia Z. Romero-Mendez, Robert L. Geahlen, Harm HogenEsch, Stanley L. Hem,